Terms: = Prostate cancer AND ARNT, HIF1BETA, 405, ENSG00000143437, P27540, HIF-1beta, HIF1B, TANGO AND Staging
3 results:
1. Multi-Institutional Clinical Outcomes of Biopsy Gleason Grade Group 5 prostate cancers Treated With Contemporary High-Dose Radiation and Long-Term Androgen Deprivation Therapy.
Chilukuri S; Mallick I; Agrawal A; Maitre P; Arunsingh M; James FV; Kataria T; Narang K; Gurram BC; Anand AK; Utreja N; Dutta D; Pavamani S; Mitra S; Mallik S; Mahale N; Chandra M; Chinnachamy AN; Shahid T; Raghunathan MS; Kannan V; Mohanty SK; Basu T; Hotwani C; Panigrahi G; Murthy V
Clin Oncol (R Coll Radiol); 2023 Jul; 35(7):454-462. PubMed ID: 37061457
[TBL] [Abstract] [Full Text] [Related]
2. Prospective Comparison of PET Imaging with PSMA-Targeted
Rowe SP; Li X; Trock BJ; Werner RA; Frey S; DiGianvittorio M; Bleiler JK; Reyes DK; Abdallah R; Pienta KJ; Gorin MA; Pomper MG
J Nucl Med; 2020 Feb; 61(2):183-188. PubMed ID: 31451492
[TBL] [Abstract] [Full Text] [Related]
3. Normalization of prostate specific antigen in patients treated with intensity modulated radiotherapy for clinically localized prostate cancer.
Schmitz MD; Padula GD; Chun PY; Davis AT
Radiat Oncol; 2010 Sep; 5():80. PubMed ID: 20846422
[TBL] [Abstract] [Full Text] [Related]
